Company: OSRH
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076461
Chunk: 70

Company: OSR Holdings, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 2
Chunk 70
---
 and will not result
in immediate dilution for existing OSRH shareholders .

Strategic Outlook

Both initiatives reflect OSRH’s ongoing commitment to enhancing
shareholder value through innovative business strategies and investments in high-growth sectors. We will continue to evaluate and pursue
opportunities that align with our strategic vision, particularly in the areas of blockchain and healthcare technology. As these initiatives
progress, we will provide further updates to shareholders, ensuring transparency and compliance with all relevant regulatory requirements.

1Continuous Glucose Monitoring, 2 Market data from
gminsights.com

26

Result of Operations

Comparison of the Three Months Ended June 30, 2024 and 2025

The following tables present OSR Holdings’ statements of operations
for the three- and six-month periods ended June 30, 2024 and 2025, and percentage change between the two periods:

    Three Months Ended June 30, 

    2024  
    2025  
    Change $  
    Change % 
  
    Net Sales: 
     881,829  
     1,135,517  
     253,688  
     29%
  
    Cost of Sales 
     649,509  
     1,102,735  
     453,226  
     70%
  
    Gross Profit 
     232,321  
     32,782  
     -199,539  
     -86%
  
    Expenses: 

    Selling, general and administrative expenses 
     3,442,428  
     5,261,960  
     1,819,532  
     53%
  
    Operating loss 
     (3,210,108) 
     (5,229,177) 
     -2,019,069  
     63%
  
    Other income (expense) 
     (41,007) 
     3,979  
     44,986  
     -110%
  
    Profit (loss) before income taxes 
     (3,251,115) 
     (5,225,198) 
     -1,974,083  
     61%

    Six Months Ended June 30, 

    2024  
    2025  
    Change $  
    Change % 
  
    Net Sales: